Northcott John Insider Trades

Insider Trading History

Track insider trading activity for Northcott John. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Nektar Therapeutics
Nektar Therapeutics NKTR
SVP & Chief Commercial Officer
Holding Value $15M 223,210 shares
Last Trade
May 16, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$18.1k 4,592 shares
$3.95
$67.17
Nektar Therapeutics
Nektar Therapeutics NKTR
SVP & Chief Commercial Officer
Holding Value $15.3M 227,802 shares
Last Trade
Feb 16, 2022 Sale (Open Market)Shares sold on the open market or in a private sale.
$53.1k 4,852 shares
$10.95
$67.17
Nektar Therapeutics
Nektar Therapeutics NKTR
SVP & Chief Commercial Officer
Holding Value $15.6M 232,654 shares
Last Trade
Dec 16, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$888k 67,150 shares
$13.22
$67.17
Nektar Therapeutics
Nektar Therapeutics NKTR
SVP & Chief Commercial Officer
Holding Value $13.1M 194,854 shares
Last Trade
Nov 16, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$79.8k 6,061 shares
$13.16
$67.17
Nektar Therapeutics
Nektar Therapeutics NKTR
SVP & Chief Commercial Officer
Holding Value $13.5M 200,915 shares
Last Trade
Aug 16, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$85.6k 6,192 shares
$13.83
$67.17
Nektar Therapeutics
Nektar Therapeutics NKTR
SVP & Chief Commercial Officer
Holding Value $13.9M 207,107 shares
Last Trade
May 17, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$111k 6,085 shares
$18.30
$67.17
Nektar Therapeutics
Nektar Therapeutics NKTR
SVP & Chief Commercial Officer
Holding Value $14.3M 213,192 shares
Last Trade
Feb 16, 2021 Sale (Open Market)Shares sold on the open market or in a private sale.
$344k 15,358 shares
$22.37
$67.17
Nektar Therapeutics
Nektar Therapeutics NKTR
SVP & Chief Commercial Officer
Holding Value $15.4M 228,550 shares
Last Trade
Dec 18, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$535k 28,550 shares
$18.75
$67.17
Nektar Therapeutics
Nektar Therapeutics NKTR
SVP & Chief Commercial Officer
Holding Value $3.43M 51,000 shares
Last Trade
Dec 18, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$956k 51,000 shares
$18.75
$67.17
Nektar Therapeutics
Nektar Therapeutics NKTR
SVP & Chief Commercial Officer
Holding Value $13.4M 200,000 shares
Last Trade
Dec 02, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.9M 200,000 shares
$19.48
$67.17
Nektar Therapeutics
Nektar Therapeutics NKTR
SVP & Chief Commercial Officer
Holding Value $13.4M 200,000 shares
Last Trade
Dec 02, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.9M 200,000 shares
$19.48
$67.17
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Vp, Marketing, Comm Strategy
Holding Value $71.6k 33,750 shares
Last Trade
Mar 02, 2015 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$75k 11,250 shares
$6.66
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Vp, Marketing, Comm Strategy
Holding Value $23.9k 11,250 shares
Last Trade
Mar 02, 2015 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$75k 11,250 shares
$6.66
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Vp, Marketing, Comm Strategy
Holding Value $17.5k 8,235 shares
Last Trade
Mar 02, 2015 Sale (In-Kind)Shares used to pay exercise costs or tax withholding, or another in-kind transfer tied to compensation.
$20.1k 3,015 shares
$6.66
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Vp, Marketing, Comm Strategy
Holding Value $1.02M 482,400 shares
Last Trade
Feb 05, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.15M 482,400 shares
$6.53
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Vp, Marketing, Comm Strategy
Holding Value $256k 120,600 shares
Last Trade
Feb 05, 2015 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$788k 120,600 shares
$6.53
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Vp, Marketing, Comm Strategy
Holding Value $0 0 shares
Last Trade
Jul 24, 2014 Sale
$482k 45,000 shares
$10.71
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Vp, Marketing, Comm Strategy
Holding Value $0 0 shares
Last Trade
Jul 24, 2014 Sale
$1.12M 105,000 shares
$10.71
$2.12
Lexicon Pharmaceuticals
Lexicon Pharmaceuticals LXRX
Vp, Marketing, Comm Strategy
Holding Value $0 0 shares
Last Trade
Jul 24, 2014 Sale
$1.29M 120,000 shares
$10.71
$2.12

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up